Catch the replay of Sona Nanotech’s May 15th investor webinar for insights into the next steps toward first-in-human studies for Sona’s targeted hyperthermia therapy cancer treatment, featuring CEO David Regan and CMO Dr. Carman Giacomantonio.
Catch the replay of Sona Nanotech’s May 15th investor webinar for insights into the next steps toward first-in-human studies for Sona’s targeted hyperthermia therapy cancer treatment, featuring CEO David Regan and CMO Dr. Carman Giacomantonio.